Health
Coronavirus vaccine by AstraZeneca begins late-stage US study – 7NEWS.com.au
The company enlisted by Australia as its primary hope for a vaccine has announced a promising step.
AstraZeneca has begun enrolling adults for a US-funded, 30,000-subject late-stage study of its high profile COVID-19 vaccine candidate.
Trial participants will receive either two doses of the experimental vaccine, dubbed AZD1222, four weeks apart, or a placebo, the company said on Monday.
Should the trials prove successful, Australians may be in line to receive the AstraZeneca vaccine.
The trial is being conducted under the US governments Operation Warp Speed program.
The program aims to acc…
-
Noosa News21 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General21 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News13 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General10 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania